Alafi Christopher D

Insider Buys Quantity –
34
2021-05-28SaleIntra-Cellular Therapies, Inc.
ITCI
director
38,843
0.0487%
$40.12$1.56M+9.11%
2021-05-27SaleIntra-Cellular Therapies, Inc.
ITCI
director
8,482
0.0106%
$40.01$339,365+8.81%
2021-05-24SaleIntra-Cellular Therapies, Inc.
ITCI
director
26,575
0.0346%
$40.47$1.08M+11.68%
2021-05-21SaleIntra-Cellular Therapies, Inc.
ITCI
director
1,100
0.0014%
$40.00$44,000+7.27%
2020-09-14PurchaseIntra-Cellular Therapies, Inc.
ITCI
director
99,000
0.1382%
$29.60$2.93M+8.03%
2020-09-11PurchaseIntra-Cellular Therapies, Inc.
ITCI
director
42,000
0.0613%
$28.08$1.18M+19.17%
2019-09-10PurchaseIntra-Cellular Therapies, Inc.
ITCI
970,000
1.7329%
$10.26$9.95M+83.17%
2019-08-30PurchaseIntra-Cellular Therapies, Inc.
ITCI
director
250,000
0.4508%
$8.52$2.13M+121.14%
2019-06-12PurchaseIntra-Cellular Therapies, Inc.
ITCI
director
340,000
0.6118%
$11.73$3.99M+9.39%
2019-05-14PurchaseIntra-Cellular Therapies, Inc.
ITCI
director
200,000
0.3636%
$12.56$2.51M-0.16%
2017-12-29PurchaseIntra-Cellular Therapies, Inc.
ITCI
2,002
0.0043%
$14.48$28,989+35.53%
2017-11-22PurchaseIntra-Cellular Therapies, Inc.
ITCI
director
20,000
0.0429%
$15.55$311,000+25.05%
2017-10-02PurchaseIntra-Cellular Therapies, Inc.
ITCI
516,130
1.1169%
$15.50$8M+25.82%
2016-12-07PurchaseIntra-Cellular Therapies, Inc.
ITCI
41,652
0.0959%
$16.14$672,076-12.21%
2016-12-06PurchaseIntra-Cellular Therapies, Inc.
ITCI
88,348
0.2038%
$16.33$1.44M-13.07%
2016-11-14PurchaseIntra-Cellular Therapies, Inc.
ITCI
68,000
0.1595%
$14.50$985,939-2.73%
2016-02-29PurchaseIntra-Cellular Therapies, Inc.
ITCI
200,000
0.4891%
$29.70$5.94M+8.91%
2015-03-11PurchaseIntra-Cellular Therapies, Inc.
ITCI
1.25M
3.9466%
$24.00$30M+24.33%
2014-12-01PurchaseIntra-Cellular Therapies, Inc.
ITCI
2,844
0.0093%
$14.75$41,949+72.26%
2014-11-28PurchaseIntra-Cellular Therapies, Inc.
ITCI
70,000
0.2441%
$14.75$1.03M+83.3%